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ABSTRACT
Many biological experiments and their subsequent
analysis yield lists of genes or proteins that can
potentially be important to the prognosis or diag-
nosis of certain diseases (e.g. cancer). Nowadays,
information about the function of those genes or
proteins may be already gathered in some data-
bases, but it is essential to understand if some of
the members of those lists have a function in
common or if they belong to the same metabolic
pathway. To help researchers filter those genes or
proteins that have such information in common,
we have developed PaLS (pathway and literature
strainer, http://pals.bioinfo.cnio.es). PaLS takes a
list or a set of lists of gene or protein identifiers
and shows which ones share certain descriptors.
Four publicly available databases have been used
for this purpose: PubMed, which links genes with
those articles that make reference to them; Gene
Ontology, an annotated ontology of terms related to
the cellular component, biological process or mole-
cular function where those genes or proteins are
involved; KEGG pathways and Reactome pathways.
Those descriptors among these four sources of
information that are shared by more members of the
list (or lists) are highlighted by PaLS.
INTRODUCTION
Much of the software for the analysis of genomic data
yields lists of genes or proteins relevant for a given disease.
Information about common features of those genes on
these lists may have been already stored in some of the
databases publicly available. To help the user make sense
of these lists, we have created PaLS (pathway and
literature strainer), a new tool that ﬁlters out those
descriptors that are more represented in the list.
Four diﬀerent types of descriptors are considered
in PaLS: Pubmed references (1), Gene Ontology (GO)
terms (2), KEGG pathways (3), and Reactome path-
ways (4). They give an insight on the kinds of biological
processes diﬀerent genes and proteins are known to be
involved in.
PaLS is particularly useful for the biological interpreta-
tion of results from studies of diﬀerential expression and,
specially, gene selection in the context of classiﬁcation and
prediction with microarray data. In all of these cases, the
ﬁnal output are lists of ‘interesting genes’, either because
there is evidence that those genes show diﬀerential
expression among conditions, or because those genes can
be used to classify patients (e.g. when attempting to
predict good versus bad prognosis in cancer patients).
Variable selection with microarray data (in general, in
scenarios where the number of variables is much larger
than the number of samples), however, can lead to many
solutions that have similar prediction errors, but that
share few common genes (5–9). In other words, repeated
runs of the same algorithm (or of similar algorithms),
often return diﬀerent solutions: diﬀerent lists of ‘inter-
esting genes’ that share few, if any, genes. These diﬀerent
solutions, however, even if diﬀerent in terms of the
individual genes selected, are frequently equivalent in the
sense that they lead to the same predictions for subjects
and have similar estimated prediction error rates. This
multiplicity of results (many lists of genes that share few
genes) is not a problem when the only objective of our
method is prediction, but it is problematic for the
biological interpretability of the results (5). Which one
of the solutions, or sets of interesting genes, should we
choose? Moreover, choosing one set of genes without
awareness of the multiple solutions can create a false
perception that the selected set is distinct from the rest of
the genes. Instead of focusing on the identity of the
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individual genes selected, PaLS allows us to try to discover
the major biological themes (e.g. main biological path-
ways) that are shared among diﬀerent solutions, even if
the identity of the genes in each solution is diﬀerent. For
instance, it is straightforward to use PaLS on diﬀerent
cross-validation or bootstrap runs in a classiﬁcation or
prediction study. An example will be shown below.
There are other tools with a similar goal to PaLS:
Genecodis (10) shows most cited GO terms, KEGG
pathways, InterProf motifs and SwissProt keywords, but
it has to be rerun for each database, making it cumber-
some to use as an exploratory tool; GeneTools (11) and
FatiGO (12) only consider GO terms and, thus, have a
much more limited scope than PaLS; and DAVID Gene
Functional Classiﬁcation Tool (13) takes a list of
identiﬁers and it clusters them into groups based on
their common descriptors, while PaLS does it the other
way around: it shows those descriptors that are common
within each list of identiﬁers.
FUNCTIONALITY
The main input ﬁle for PaLS is a plain text ﬁle containing
a list or several lists of gene or protein identiﬁers. Each list
can have its own name, which has to appear at the top of
the list, after the ‘#’ symbol. The types of identiﬁers
accepted by the application are: Ensembl Gene IDs,
UniGene cluster IDs, Gene names (HUGO), GenBank
accessions, Clone IDs, Aﬀymetrix IDs, EntrezGene IDs,
RefSeq_RNAs, RefSeq_peptides, SwissProt names. Thus,
all of the main types of identiﬁers in common use are
covered by PaLS. If a given identiﬁer from the input list is
not found on the database it is removed from the analysis.
Data for three diﬀerent organisms is accepted: human,
mouse and rat. Internally, using the database of pre-
generated conversion of identiﬁers used by IDconverter
(14), PaLS does all the necessary translation of identiﬁers
using the paths displayed in http://pals.bioinfo.cnio.es/
help/PaLS-schema.png.
PaLS has three diﬀerent methods of ﬁltering
annotations:
 Filter those descriptors that are referenced by more than
a given percentage of identiﬁers, giving results for each
list separately. This method of ﬁltering is intended to be
used as a way of discerning which list, among the lists
that a predictive software can output, has some common
previously published information that shows that those
genes or proteins share a similar function.
 Group all lists in one list (removing duplicates) and
display those descriptors that are more referenced in
this global list. This method allows the user to see
commonalities even if they are not seen within each list.
 Look for those descriptors that are referenced by more
than a given threshold of identiﬁers in more than a
given percentage of lists. This allows looking for
commonalities present within and among sets of lists.
Threshold values for the percentage of appearance of
each of the type of the descriptors are part of the input
information needed, but they have a default value of 50%.
Specially for PubMed references, and due to the
popular tendency of genomics articles citing thousands
of genes, it is suggested to use lower thresholds to obtain
results that may be more speciﬁc than general articles. For
all types of descriptors, the most time consuming process
is the ﬁrst search; once this is completed, the user can
change thresholds for each type of descriptor and ﬁltering
method, and obtain an answer in a short time.
The output of PaLS are lists of those descriptors that
fulﬁll the threshold criteria selected by the user, and the
input identiﬁers related to each descriptor, linked to
IDClight (14) to present the user with as much informa-
tion as possible. This process is depicted in Figure 1. Also,
for lists of less than 100 nodes, graph plots that describe
the data structure of the lists are created. These plots
(Figure 2), show all the genes or proteins in the list that
have at least one descriptor as nodes. Two nodes (genes or
proteins) are linked if they have descriptors in common;
the more descriptors they share, the closer they appear.
We use GO as a controlled vocabulary. For a gene or
protein, we reach GO through Ensembl which, in turn,
depends on Uniprot. Thus, we make no attempt to
incorporate the complete ontology (e.g. for a given gene
not all the parent terms are included) nor its relationships.
There are four reasons for our choice. First, we use the
same approach as provided by a trusted, experienced
source (Ensembl). Second, incorporating the complete
ontology and/or the possible ontological relationships is
not without additional problems, such as at what level of
the ontology to search for commonalities or which of the
ﬁve possible relationships to consider; by relying on the
Ensembl mapping we avoid having to make this decisions
ourselves. Third, since we provide links to AmiGO, it is
easy for users to navigate the ontologies. Fourth, it would
be possible to incorporate other sources of information
like GO slims (http://www.geneontology.org/GO.slims.
shtml), which are cut-down versions of GO which might
be tailored for speciﬁc purposes; it should also be possible
to add searches that attempt to incorporate more of the
ontological information, or a more ‘semantically aware’
analysis. However, as explained above, we have tried to
avoid imposing our own arbitrary decisions or our own
semantical/ontological models and have preferred,
instead, to rely on a standard source of GO annotations.
IMPLEMENTATION
PaLS is written in Python and uses AJAX to display the
results, as well as NetworkX (https://networkx.lanl.gov), a
Python package, to create the graph plots. The database
server is MySQL and it is populated through a series of
Perl and Python scripts (14). All the possible conversions
are pregenerated in order to dramatically improve the
response time of the application. The process of pregener-
ating these conversions is done every 2 months, following
Ensembl’s update schedule, using the latest version avail-
able of each of the databases used: Ensembl, UniGene,
PubMed, KEGG, Reactome and Gene Ontology. For
now, human, mouse and rat are the only organisms
considered by PaLS; however, if needed or required by the
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community, the backbone of the same scripts that
pregenerate the conversions for these three organisms
could be used to add any of the tens of organisms for
which there are data in Ensembl, provided that the
corresponding UniGene databases are also available. All
codes are available on request from the authors under the
GPL license.
EXAMPLE
As an example, we have used our application SignS (15)
with the data set from van’t Veer et al. (16) as provided in
Bair and Tibshirani (17). The original names contained a
mixture of types of identiﬁers. For the example, we have
mapped all possible identiﬁers to RefSeq_RNA. The
results from SignS are available at http://signs.bioinfo.
cnio.es/Examples/vantVeer-FCMS/results.html, and those
from PaLS can be found at http://pals.bioinfo.cnio.es/
Examples/vantVeer-FCMS/results.html.
At 50% threshold, GO terms in most lists refer to
‘nucleus’. At the 40% threshold, the term ‘cell cycle’
appears in several of the lists. As reported in the original
van’t Veer et al. paper (16), genes involved in cell cycle are
upregulated in the poor prognosis signature, which agrees
with the results from SignS and PaLS (the IDs correspond
to a signature in SignS associated with decreased survival).
If we drill down further, and set the threshold at 20%, we
see that ‘mitosis’ appears in most of the lists; again, this is
a functional annotation that the original publication
describes as common in genes associated with poor prog-
nosis. DNA repair (and, thus, GO term ‘signal transduc-
tion’, mentioned in the original reference) can be found in
some lists at lower thresholds. If we examine PaLS results
from Reactome, at the 20% threshold we see that ‘Cell
cycle.Mitotic’ is abundant in most of the lists. Interest-
ingly, one of the lists (the 6th cross-validation run) shows
‘E2F mediated regulation of DNA replication’, and van’t
Figure 1. PaLS processing steps. Starting from a list or lists of protein or gene identiﬁers (A), PaLS looks for all their descriptors in the same database of
ID conversions pregenerated for IDconverter (14) (B). Finally, it sorts those descriptors that appear more often in the lists, so the user can get an idea of
the of the relevance of their lists (C). This example is done with a list of cancer-related genes available in the Help section of the web server.
Figure 2. Example of a graph plot produced by PaLS (generated with
the NetworkX package). The graph shows, for list from the 7th cross-
validation run, those RefSeq_RNAs that are connected through
common Gene Ontology terms. It can be seen how there is a central
group of genes that share more terms (as they are closer to each other),
and a gene, NM_006623, on the right side, that is only connected to
another gene of the list.
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Veer et al. mention cyclin E2. The fact that we need to use
relatively low thresholds suggests, however, that there is
no ‘dominant theme’ among the results: genes seem to
belong to diﬀerent groups in terms of their functional
categories and pathways.
Figure 2 shows an example of the graph plots generated
by PaLS, that display the connectivity structure of the
input lists.
CONCLUSIONS AND FURTHER DEVELOPMENT
PaLS is a useful tool that helps researchers in their
genomic analysis, improving the potential meaningfulness
and biological interpretability of any list of genes or
proteins that the analysis may yield. Given its diﬀerent
ways of sorting out those descriptors that are more
relevant, PaLS can fulﬁll most of the ﬁltering needs of the
user, providing a list of useful descriptors that enrich the
knowledge associated with a given list. It is important to
note that this ﬁltering is done without depending on any
statistical model. Also, due to its modular characteristics,
it can be easily improved with the addition of new types of
descriptors.
Among some further worthwhile developments, either
for public or private versions, PaLS could include queries
to speciﬁc, tailored GO databases (such as GO slims) as
well as ﬁltered queries to PubMed, maybe using Natural
Language Processing, or ﬁltering papers according to
some predetermined criteria that might be relevant in
certain institutions or research environments.
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